PT  - JOURNAL ARTICLE
AU  - Dawer, Aleena
AU  - Msengi, Victor
AU  - Mtui, Theresia B.
AU  - Sarakikya, Sarah
AU  - Suleiman, Rashid
AU  - Lusingu, John P. A.
TI  - Antimicrobial resistance of bacteria isolates among patients with chronic wound infections in Tanga Regional Referral Hospital, Tanzania
AID  - 10.1101/2024.11.29.24318063
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.11.29.24318063
4099  - http://medrxiv.org/content/early/2024/12/01/2024.11.29.24318063.short
4100  - http://medrxiv.org/content/early/2024/12/01/2024.11.29.24318063.full
AB  - Background Bacterial wound infections are the second leading cause of mortality globally, with approximately 50% of contaminated wounds evolving into chronic infections. In Tanzania, this challenge is exacerbated by the over prescription of antibiotics and the emergence of drug-resistant bacteria, compounded by inadequate hospital hygiene and sanitation practices. This study investigated chronic wound infections in Tanga, Tanzania, focusing on antibiotic susceptibility patterns.Methods A cross-sectional, mixed-methods study was conducted at the Tanga Regional Referral Hospital (TRRH) from July 2023 to December 2023. Pus and Culture Sensitivity tests were performed on samples from 89 chronic wound patients to identify bacterial isolates and assess antibiotic susceptibility. Data was analyzed using STATA, Excel, and Python.Results Of 89 patients, 82 (92.1%) had positive bacterial isolates in wound cultures, predominantly with Staphylococcus aureus, 24 (29.3%). Surgical-site infections (SSI) were the most prevalent diagnosis, followed by diabetic foot ulcers and septic wounds. Antibiotic resistance analysis revealed a marked trend in multi-drug resistance (MDR), notably against amoxicillin, while meropenem was identified as the most effective antibiotic.Conclusion The elevated rate of MDR at TRRH, particularly against commonly used antibiotics, emphasizes the need for improved antibiotic stewardship and healthcare worker education. It necessitates increased health awareness about effective wound management and the development of robust healthcare strategies to combat the escalating challenge of MDR.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by a research grant from Georgetown University, awarded to AD and JPAL for conducting research in Tanzania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The National Health Research Ethics Review Committee of the National Institute for Medical Research, Tanzania gave ethical approval for this work (Reference: NIMR/HQ/R.8a/Vol.IX/4443). The approval is valid from 27 October 2023 to 26 October 2024. Ethical approval from the Institutional Review Board (IRB) of Georgetown University was not required for this study as per the university's policy, given that the research was conducted in collaboration with a host institution under the ethical framework of the National Institute for Medical Research, Tanzania.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe dataset underlying this study has been fully anonymized to protect patient confidentiality and has been made available in the Dryad repository. It can be accessed at https://doi.org/10.5061/dryad.z08kprrq3. The dataset includes variables related to patient demographics, diagnoses, antimicrobial resistance patterns, and hospitalization durations. All personally identifiable information has been removed to ensure compliance with ethical guidelines. https://datadryad.org/stash/share/o8XJQKJH7tVM6SnBA5wY0K9-nV9S5VZc0MCY52h24V4